122 related articles for article (PubMed ID: 23465060)
1. Unraveling the mechanisms behind the enhanced MTT conversion by irradiated breast cancer cells.
Blockhuys S; Vanhoecke B; Smet J; De Paepe B; Van Coster R; Bracke M; De Wagter C
Radiat Res; 2013 Apr; 179(4):433-43. PubMed ID: 23465060
[TBL] [Abstract][Full Text] [Related]
2. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
van Tonder A; Joubert AM; Cromarty AD
BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes.
Isobe I; Michikawa M; Yanagisawa K
Neurosci Lett; 1999 May; 266(2):129-32. PubMed ID: 10353344
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.
Berridge MV; Tan AS
Arch Biochem Biophys; 1993 Jun; 303(2):474-82. PubMed ID: 8390225
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.
McGowan EM; Alling N; Jackson EA; Yagoub D; Haass NK; Allen JD; Martinello-Wilks R
PLoS One; 2011; 6(6):e20623. PubMed ID: 21673993
[TBL] [Abstract][Full Text] [Related]
6. The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC.
Bernas T; Dobrucki JW
Arch Biochem Biophys; 2000 Aug; 380(1):108-16. PubMed ID: 10900139
[TBL] [Abstract][Full Text] [Related]
7. Tetrazolium [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] reduction by mycoplasmas.
Kirchhoff H; Maass C; Runge M; Franz B; Schmidt R; Quentmeier H; Mühlradt PF
Int J Syst Bacteriol; 1992 Jul; 42(3):506-8. PubMed ID: 1503978
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of MTT assay for measurement of emodin-induced cytotoxicity.
Wang X; Ge J; Wang K; Qian J; Zou Y
Assay Drug Dev Technol; 2006 Apr; 4(2):203-7. PubMed ID: 16712424
[TBL] [Abstract][Full Text] [Related]
9. Cell sensitivity assays: the MTT assay.
van Meerloo J; Kaspers GJ; Cloos J
Methods Mol Biol; 2011; 731():237-45. PubMed ID: 21516412
[TBL] [Abstract][Full Text] [Related]
10. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
Shearman MS; Hawtin SR; Tailor VJ
J Neurochem; 1995 Jul; 65(1):218-27. PubMed ID: 7790863
[TBL] [Abstract][Full Text] [Related]
11. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival.
Pagliacci MC; Spinozzi F; Migliorati G; Fumi G; Smacchia M; Grignani F; Riccardi C; Nicoletti I
Eur J Cancer; 1993; 29A(11):1573-7. PubMed ID: 8217365
[TBL] [Abstract][Full Text] [Related]
12. Substrate-Specific Reduction of Tetrazolium Salts by Isolated Mitochondria, Tissues, and Leukocytes.
Fedotcheva NI; Litvinova EG; Zakharchenko MV; Khunderyakova NV; Fadeev RS; Teplova VV; Fedotcheva TA; Beloborodova NV; Kondrashova MN
Biochemistry (Mosc); 2017 Feb; 82(2):192-204. PubMed ID: 28320303
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte proliferation response during Eimeria tenella infection assessed by a new, reliable, nonradioactive colorimetric assay.
Miyamoto T; Min W; Lillehoj HS
Avian Dis; 2002; 46(1):10-6. PubMed ID: 11922320
[TBL] [Abstract][Full Text] [Related]
14. Superoxide-dependent and superoxide-independent pathways for reduction of nitroblue tetrazolium in isolated rat cardiac myocytes.
Thayer WS
Arch Biochem Biophys; 1990 Jan; 276(1):139-45. PubMed ID: 1688694
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
Kubo T; Nishimura S; Oda T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):94-100. PubMed ID: 12393269
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
Liu Y; Peterson DA; Kimura H; Schubert D
J Neurochem; 1997 Aug; 69(2):581-93. PubMed ID: 9231715
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of MTT as an indicator of viability and respiratory burst activity of human neutrophils.
Pruett SB; Loftis AY
Int Arch Allergy Appl Immunol; 1990; 92(2):189-92. PubMed ID: 2242930
[TBL] [Abstract][Full Text] [Related]
18. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line.
Ngamwongsatit P; Banada PP; Panbangred W; Bhunia AK
J Microbiol Methods; 2008 Jun; 73(3):211-5. PubMed ID: 18417231
[TBL] [Abstract][Full Text] [Related]
19. Gamma irradiation effects on cultured cells: investigated by the MTT method.
Bunnak J; Takigami M; Ito H; Shinozawa T
J Radiat Res; 1994 Dec; 35(4):205-12. PubMed ID: 7752104
[TBL] [Abstract][Full Text] [Related]
20. Cell Enumeration Assays: Application of the MTT and Sulforhodamine B Assays to Lipopolysaccharide-Stimulated Neonatal Rodent Microglia.
Facci L; Skaper SD
Methods Mol Biol; 2018; 1727():167-178. PubMed ID: 29222781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
